Both VNG1.47 and IGS2.7 efficiently reduced TDP-43 hyperphosphorylation in severe AD lymphoblasts, and restored the nuclear/cytosolic TDP-43 ratio to values similar to those observed in control lymphoblasts. Here, TARDBP is linked to Alzheimer disease.